Steris Reports Q4 2026 Earnings with Mixed Financial Results
Steris (STE) reported a 7% year-over-year revenue growth for the fourth quarter of fiscal 2026, driven by volume and price increases. However, gross margin declined due to inflation and tariffs, while free cash flow exceeded expectations despite weaker working capital performance.
Tickers: $STE
Topics: financial_performance free_cash_flow margin_changes revenue_growth